The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study
Cancers（2023）
关键词
metastatic melanoma,unresectable melanoma,dabrafenib,trametinib,lactate dehydrogenase,BRAF V600 mutation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要